[Vaccine therapy of recurrent rhinopharyngeal catarrhal diseases].
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008297:Male; D008875:Middle Aged; D009302:Nasopharyngeal Diseases / Q000628:therapy*; D010612:Pharyngitis / Q000628:therapy*; D012130:Respiratory Hypersensitivity / Q000628:therapy*; D012141:Respiratory Tract Infections / Q000628:therapy*; D012220:Rhinitis / Q000628:therapy*; D012852:Sinusitis / Q000628:therapy*
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents
Vaccinoterapia delle affezioni catarrali rinofaringee recidivanti.